QL-IX-55TORC1/TORC2 inhibitor CAS# 1223002-54-7 |
- WYE-354
Catalog No.:BCC1059
CAS No.:1062169-56-5
- GDC-mTOR inhibitor
Catalog No.:BCC1781
CAS No.:1207358-59-5
- GDC-0349
Catalog No.:BCC1094
CAS No.:1207360-89-1
- LY 303511
Catalog No.:BCC1715
CAS No.:154447-38-8
- Nordihydroguaiaretic acid
Catalog No.:BCC1805
CAS No.:500-38-9
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 1223002-54-7 | SDF | Download SDF |
| PubChem ID | 51350805 | Appearance | Powder |
| Formula | C24H14F4N4O | M.Wt | 450.39 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | DMSO | ||
| Chemical Name | 9-(6-aminopyridin-3-yl)-1-[4-fluoro-3-(trifluoromethyl)phenyl]benzo[h][1,6]naphthyridin-2-one | ||
| SMILES | C1=CC2=NC=C3C=CC(=O)N(C3=C2C=C1C4=CN=C(C=C4)N)C5=CC(=C(C=C5)F)C(F)(F)F | ||
| Standard InChIKey | MXRMEHBVJBSIPI-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C24H14F4N4O/c25-19-5-4-16(10-18(19)24(26,27)28)32-22(33)8-3-15-12-30-20-6-1-13(9-17(20)23(15)32)14-2-7-21(29)31-11-14/h1-12H,(H2,29,31) | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
QL-IX-55 Dilution Calculator
QL-IX-55 Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.2203 mL | 11.1015 mL | 22.203 mL | 44.406 mL | 55.5074 mL |
| 5 mM | 0.4441 mL | 2.2203 mL | 4.4406 mL | 8.8812 mL | 11.1015 mL |
| 10 mM | 0.222 mL | 1.1101 mL | 2.2203 mL | 4.4406 mL | 5.5507 mL |
| 50 mM | 0.0444 mL | 0.222 mL | 0.4441 mL | 0.8881 mL | 1.1101 mL |
| 100 mM | 0.0222 mL | 0.111 mL | 0.222 mL | 0.4441 mL | 0.5551 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
The functional target of QL-IX-55 is the ATP-binding site of TOR2 as evidenced by the discovery of resistant alleles of TOR2 through rational design and unbiased selection strategies. QL-IX-55 is capable of potently inhibiting both TOR complex 1 and 2 (TORC1 and TORC2) as demonstrated by biochem. IP kinase assays (IC50 <50 nM) and cellular assays for inhibition of substrate YPK1 phosphorylation. In contrast to rapamycin, QL-IX-55 is capable of inhibiting TORC2-dependent transcription, which suggests that this compd. will be a powerful probe to dissect the Tor2/TORC2-related signaling pathway in yeast.
- Torin 2
Catalog No.:BCC4606
CAS No.:1223001-51-1
- Torin 1
Catalog No.:BCC3676
CAS No.:1222998-36-8
- ML324
Catalog No.:BCC5575
CAS No.:1222800-79-4
- ML133 HCl
Catalog No.:BCC5006
CAS No.:1222781-70-5
- 3-Epimeliasenin B
Catalog No.:BCN4723
CAS No.:1222475-77-5
- Boc-Dap(Fmoc)-OH
Catalog No.:BCC2665
CAS No.:122235-70-5
- 5'-Geranyl-5,7,2',4'-tetrahydroxyflavone
Catalog No.:BCN1601
CAS No.:1221762-70-4
- NPS-1034
Catalog No.:BCC6504
CAS No.:1221713-92-3
- Gymnemic acid I
Catalog No.:BCN2679
CAS No.:122168-40-5
- Skepinone-L
Catalog No.:BCC1953
CAS No.:1221485-83-1
- BP 554 maleate
Catalog No.:BCC6695
CAS No.:1221401-95-1
- Meliasenin B
Catalog No.:BCN6112
CAS No.:1221262-77-6
- Vermisporin
Catalog No.:BCN1863
CAS No.:122301-98-8
- 6''-O-acetylisovitexin
Catalog No.:BCN6114
CAS No.:1223097-20-8
- Rosiglitazone
Catalog No.:BCC2264
CAS No.:122320-73-4
- Amylin
Catalog No.:BCC6017
CAS No.:122384-88-7
- Paederosidic acid methyl ester
Catalog No.:BCN3439
CAS No.:122413-01-8
- MFZ 10-7
Catalog No.:BCC6180
CAS No.:1224431-15-5
- 4-O-(3-nitropropanoyl)corollin
Catalog No.:BCC8716
CAS No.:122475-42-7
- GBLD 345
Catalog No.:BCC6787
CAS No.:122479-08-7
- INK 128 (MLN0128)
Catalog No.:BCC3880
CAS No.:1224844-38-5
- Gentiside B
Catalog No.:BCN7301
CAS No.:1225022-67-2
- Naltriben mesylate
Catalog No.:BCC5683
CAS No.:122517-78-6
- AG 99
Catalog No.:BCC6667
CAS No.:122520-85-8
Selective ATP-competitive inhibitors of TOR suppress rapamycin-insensitive function of TORC2 in Saccharomyces cerevisiae.[Pubmed:22496512]
ACS Chem Biol. 2012 Jun 15;7(6):982-7.
The target of rapamycin (TOR) is a critical regulator of growth, survival, and energy metabolism. The allosteric TORC1 inhibitor rapamycin has been used extensively to elucidate the TOR related signal pathway but is limited by its inability to inhibit TORC2. We used an unbiased cell proliferation assay of a kinase inhibitor library to discover QL-IX-55 as a potent inhibitor of S. cerevisiae growth. The functional target of QL-IX-55 is the ATP-binding site of TOR2 as evidenced by the discovery of resistant alleles of TOR2 through rational design and unbiased selection strategies. QL-IX-55 is capable of potently inhibiting both TOR complex 1 and 2 (TORC1 and TORC2) as demonstrated by biochemical IP kinase assays (IC(50) <50 nM) and cellular assays for inhibition of substrate YPK1 phosphorylation. In contrast to rapamycin, QL-IX-55 is capable of inhibiting TORC2-dependent transcription, which suggests that this compound will be a powerful probe to dissect the Tor2/TORC2-related signaling pathway in yeast.
